Relief Therapeutics Holding SA Sustainability Reports
The company operates as a commercial-stage biopharmaceutical and neurotechnology company developing digital and biological treatments for neurological diseases, brain disorders, and rare indications.
Sector: Manufacturing
Country: Switzerland
Exchange: SIX Swiss Exchange
LEI: 506700IT19260EVD7916
FIGI: BBG001SLFQ79
6 reports from 2019 to 2024